February 21, 2024

Iceland’s iStopMM Study Revises Definition of Free Light Chains in Serum and Light Chain Monoclonal Gammopathy of Undetermined Significance (MGUS) 

Thorir Einarsson Long, MD, PhD, (University of Iceland — Reykjavík, Iceland) discusses how the iStopMM trial, a large population-based study, focused on individuals with estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73m2. Results of the study led to redefined reference intervals for patients with chronic kidney disease.     

Watch the video now…